Elite Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Elite Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-6,878	Closed	-$654K	–	42
2019 Q4	$654K	Sell	6,878 -53	-0.8%	-$4.58K	0.37%	18
2019 Q3	$528K	Sell	6,931 -483	-7%	-$40.1K	0.73%	19
2019 Q2	$650K	Sell	7,414 -531	-7%	-$45.3K	0.88%	15
2019 Q1	$719K	Sell	7,945 -1,120	-12%	-$95.3K	1.33%	15
2018 Q4	$650K	Buy	9,065 +160	+2%	+$12.9K	0.63%	32
2018 Q3	$854K	Sell	8,905 -23	-0.3%	-$2.23K	0.18%	33
2018 Q2	$850K	Buy	8,928 +459	+5%	+$42.2K	0.3%	32
2018 Q1	$743K	Buy	8,469 +244	+3%	+$22.3K	0.61%	35
2017 Q4	$698K	Buy	+8,225	New	+$689K	0.59%	37
2016 Q3	$796K	Sell	12,012 -2,791	-19%	-$173K	1.3%	22
2016 Q2	$800K	Sell	14,803 -2,831	-16%	-$155K	1.32%	24
2016 Q1	$910K	Buy	17,634 +1,509	+9%	+$78.4K	1.28%	23
2015 Q4	$1.13M	Buy	16,125 +5,097	+46%	+$348K	1.68%	20
2015 Q3	$686K	Sell	11,028 -3,762	-25%	-$296K	1.08%	39
2015 Q2	$1.24M	Sell	14,790 -2,037	-12%	-$158K	1.29%	27
2015 Q1	$1.26M	Buy	+16,827	New	+$1.18M	1.12%	33

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Elite Wealth Management's XBI Position: Q1 2020 in Review

Elite Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2020, closing a stake of 6,878 shares — an estimated $654K sold.

Elite Wealth Management first reported a position in XBI in Q1 2015 and held it in 16 quarters. The position peaked at $1.26M in Q1 2015. 458 funds tracked by Wall St. Rank hold XBI as of Q1 2020.

Elite Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2020 after selling out during the quarter.
Elite Wealth Management sold 6,878 State Street SPDR S&P Biotech ETF shares in Q1 2020, an estimated $654K.
Elite Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and held it in 16 quarters.
Elite Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $1.26M in Q1 2015.
458 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2020.

Based on Elite Wealth Management's 13F filing for Q1 2020, filed 16 Apr 2020.